文献
J-GLOBAL ID:201902232479095634
整理番号:19A0176874
MTB PKNa/PKNB二重阻害は宿主キナーゼ相互作用を最小化するための阻害剤設計の選択性利点を提供する【JST・京大機械翻訳】
Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions
著者 (16件):
Wang Tiansheng
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Bemis Guy
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Hanzelka Brian
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Zuccola Harmon
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Wynn Michael
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Moody Cameron Stuver
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Green Jeremy
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Locher Christopher
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Liu Aixiang
(Shanghai ChemPartner Co. Ltd., China)
,
Gao Hongwu
(Shanghai ChemPartner Co. Ltd., China)
,
Xu Yuzhou
(Shanghai ChemPartner Co. Ltd., China)
,
Wang Shaohui
(Shanghai ChemPartner Co. Ltd., China)
,
Wang Jie
(Shanghai ChemPartner Co. Ltd., China)
,
Bennani Youssef L.
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Thomson John A.
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
,
Mueh Ute
(Vertex Pharmaceuticals Incorporated, Massachusetts, United States)
資料名:
ACS Medicinal Chemistry Letters
(ACS Medicinal Chemistry Letters)
巻:
8
号:
12
ページ:
1224-1229
発行年:
2017年
JST資料番号:
W5043A
ISSN:
1948-5875
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)